Gavin Cull

3.0k citations

67 papers · 1.2k indexed · h-index 17

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Genetics 40
- Chronic Lymphocytic Leukemia Research 34
Pathology and Forensic Medicine 34
- Lymphoma Diagnosis and Treatment 33

Co-authors: Paula Marlton (20 shared papers)Stephen Opat (21 shared papers)Constantine S. Tam (22 shared papers)David Simpson (16 shared papers)Devinder Gill (9 shared papers)Judith Trotman (16 shared papers)Paul Cannell (3 shared papers)Javier Muñoz (9 shared papers)
Journals: Blood (17 papers)HemaSphere (5 papers)Hematological Oncology (5 papers)British Journal of Haematology (4 papers)Neuro-Oncology (3 papers)
Partner nations: Australia New Zealand United States

In The Last Decade

Gavin Cull

63 papers receiving 1.2k citations

Peers

Countries citing papers authored by Gavin Cull

Since Specialization

Citations

This map shows the geographic impact of Gavin Cull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Cull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Cull more than expected).

Fields of papers citing papers by Gavin Cull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Cull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Cull. The network helps show where Gavin Cull may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin Cull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin Cull Line = papers co-authored together Gavin Cull links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study The Lancet Oncology ·Jacoline E. C. Bromberg, Samar Issa, Katerina Bakunina, Monique C. Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Harry C. Schouten, Wendy B.C. Stevens, Josée M. Zijlstra, Joke W. Baars, Marcel Nijland, Kylie D. Mason, Aart Beeker, Martin J. van den Bent, Max Beijert, Michael Gonzales, Daphne de Jong, Jeanette K. Doorduijn	2019	162
2	Incidence and nature of CD20‐negative relapses following rituximab therapy in aggressive B‐cell non‐Hodgkin's lymphoma: a retrospective review British Journal of Haematology ·Glen Kennedy, Siok‐Keen Tey, Ralph Cobcroft, Paula Marlton, Gavin Cull, Karen Grimmett, Damien Thomson, Devinder Gill	2002	99
3	When the safety net of treatment has been removed: Patients’ unmet needs at the completion of treatment for haematological malignancies Patient Education and Counseling ·Elizabeth Lobb, David Joske, Phyllis Butow, Linda J. Kristjanson, Paul Cannell, Gavin Cull, B. Augustson	2009	77
4	Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up Blood ·Judith Trotman, Stephen Opat, David Gottlieb, David Simpson, Paula Marlton, Gavin Cull, Javier Muñoz, Alessandra Tedeschi, Andrew W. Roberts, John F. Seymour, Siminder Atwal, Yiling Yu, William Novotny, Eric Holmgren, Ziwen Tan, James Hilger, Jane Huang, Constantine S. Tam	2020	73
5	Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma Blood Advances ·Constantine S. Tam, Stephen Opat, David Simpson, Gavin Cull, Javier Muñoz, Tycel Phillips, Won Seog Kim, Simon Rule, Siminder Atwal, Rachel Wei, William Novotny, Jane Huang, Michael Wang, Judith Trotman	2021	63
6	Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH conditioning: an effective regimen with low procedure‐related toxicity British Journal of Haematology ·Gavin Cull, A. P. Haynes, Jenny Byrne, G. I. Carter, Gail Miflin, P Rebello, G Hale, Herman Waldmann, NH Russell	2000	59
7	The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia Bone Marrow Transplantation ·Jenny Byrne, C Stainer, Gavin Cull, AP Haynes, E.M. Bessell, G Hale, Herman Waldmann, NH Russell	2000	52
8	Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming Internal Medicine Journal ·Geoffrey K. Isbister, Mark Little, Gavin Cull, David McCoubrie, Paul Lawton, F. Szabó, J. C. Kennedy, Christopher Trethewy, Gary Luxton, Simon G.A. Brown, Bart J. Currie	2007	51
9	Collection and Recruitment of CD34+ Cells During Large-Volume Leukapheresis Journal of Hematotherapy ·Gavin Cull, John Ivey, Peter Chase, ROSANNA PICCIUTO, R.P. Herrmann, Paul Cannell	1997	35
10	Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study British Journal of Haematology ·Gavin Cull, Jan A. Burger, Stephen Opat, David Gottlieb, Emma Verner, Judith Trotman, Paula Marlton, Javier Muñoz, Patrick Johnston, David Simpson, J. C. Stern, Radha Prathikanti, Kenneth Wu, William Novotny, Jane Huang, Constantine S. Tam	2021	29
11	Twice Daily Dosing with the Highly Specific BTK Inhibitor, Bgb-3111, Achieves Complete and Continuous BTK Occupancy in Lymph Nodes, and Is Associated with Durable Responses in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Blood ·Constantine S. Tam, Stephen Opat, Gavin Cull, Judith Trotman, David Gottlieb, David Simpson, Paula Marlton, Mary Ann Anderson, Matthew Ku, David Ritchie, Sumita Ratnasingam, Bradley Augustson, Mark Kirschbaum, Lai Wang, Ling Xue, Jianxin Yang, Eric Hedrick, John F. Seymour, Andrew W. Roberts	2016	27
12	UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111) Hematological Oncology ·Constantine S. Tam, M. Wang, David Simpson, Stephen Opat, Gavin Cull, Javier Muñoz, Tycel Phillips, W. Kim, Siminder Atwal, R. Wei, Jennifer J. Huang, Rebecca Elstrom, Judith Trotman	2019	24
13	Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases Pathology ·Glen Kennedy, T. Kay, David W. Johnson, Carmel M. Hawley, Scott B. Campbell, Nikky Isbel, Paula Marlton, Ralph Cobcroft, Devinder Gill, Gavin Cull	2002	21
14	Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH (± fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion Cytotherapy ·Richard Lush, A. P. Haynes, Jenny Byrne, Gavin Cull, G.I. Carter, Antonio Pagliuca, Jane E. Parker, G J Mufti, P Mahendra, Charles Craddock, J. A. Liu Yin, Mamta Garg, H. G. Prentice, Michael Potter, Nigel H. Russell	2001	19
15	Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy Leukemia & lymphoma ·Steven Lane, Julie Crawford, Melita Kenealy, Gavin Cull, John F. Seymour, H. Miles Prince, Paula Marlton, Devinder Gill, Peter Mollee	2006	18
16	Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS Multiple Sclerosis Journal - Experimental Translational and Clinical ·Gavin Cull, Dustin Hall, Marzena J. Fabis‐Pedrini, W.M. Carroll, L Forster, Fiona Robins, Reza Ghassemifar, C Crosbie, Stephen J. Walters, Ian James, B. Augustson, Allan G. Kermode	2017	18
17	Treatment with the Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) Demonstrates High Overall Response Rate and Durable Responses in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Updated Results from a Phase 1/2 Trial Blood ·Gavin Cull, David Simpson, Stephen Opat, Jan A. Burger, Judith Trotman, Paula Marlton, David Gottlieb, Javier Muñoz, John F. Seymour, Andrew W. Roberts, Ken Wu, Siminder Atwal, William Novotny, Jane Huang, Constantine S. Tam	2019	18
18	An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement Cancer Medicine ·A.J. Sunderland, Raphaël Steiner, Musa Al Zahrani, Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Loretta J. Nastoupil, Mats Jerkeman, David Joske, Gavin Cull, Tarec Christoffer El‐Galaly, Diego Villa, Chan Y. Cheah	2019	16
19	Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma Internal Medicine Journal ·David Henley, Jane Kaye, John P. Walsh, Gavin Cull	2005	16
20	Anaplastic large‐cell lymphoma associated with breast implants: A unique entity within the spectrum of peri‐implant effusions Diagnostic Cytopathology ·Siaw Ming Chai, Simon Kavangh, Sin Sin Ooi, Gregory F. Sterrett, Gavin Cull, Myfanwy Plunkett, Dominic V. Spagnolo, Benhur Amanuel, David Joske, Connull Leslie, Tony Barham, Felicity Frost	2014	16

About Gavin Cull

Gavin Cull is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Neurology and Oncology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (34 papers), Lymphoma Diagnosis and Treatment (33 papers), CNS Lymphoma Diagnosis and Treatment (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Genetics (601 citations), Pathology and Forensic Medicine (662 citations), Hematology (332 citations), Neurology (230 citations) and Oncology (367 citations). Gavin Cull has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Paula Marlton, Stephen Opat, Constantine S. Tam, David Simpson, Devinder Gill, Judith Trotman, Paul Cannell, Javier Muñoz, Ralph Cobcroft and John F. Seymour. Their work appears in journals such as Blood, HemaSphere, Hematological Oncology, British Journal of Haematology and Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact